Cantor Fitzgerald Reiterates Neutral Rating on Alnylam Pharmaceuticals (ALNY)
Go back to Cantor Fitzgerald Reiterates Neutral Rating on Alnylam Pharmaceuticals (ALNY)| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 226.18 -0.94 (0.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $227.12 | 52 Week High | $109.10 | |||
| Open | $223.52 | 52 Week Low | $31.38 | |||
| Day High | $227.68 | P/E | N/A | |||
| Day Low | $220.23 | EPS | $-1.45 | |||
| Volume | 303,531 | |||||
